108 related articles for article (PubMed ID: 1451119)
1. Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
Zanolla L; Carbonieri E; Rossi L; Marino P; Zardini P
Cardiology; 1992; 80(5-6):324-31. PubMed ID: 1451119
[TBL] [Abstract][Full Text] [Related]
2. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
[TBL] [Abstract][Full Text] [Related]
3. Comparison of acute and steady-state conditions of gallopamil therapy in stable angina pectoris.
Vilchez FG; Villarroel T; Ruano Calvo J; Vazquez de Prada JA; Martin-Duran R; San Jose JM; Pajaron A
Int J Cardiol; 1992 Oct; 37(1):91-9. PubMed ID: 1428294
[TBL] [Abstract][Full Text] [Related]
4. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Hopf R; Drews H; Kaltenbach M
Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine.
Lazzeroni E; Morozzi L; Campana M; Botti G
Eur Heart J; 1992 Apr; 13(4):526-30. PubMed ID: 1600993
[TBL] [Abstract][Full Text] [Related]
6. [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study].
Rettig G; Sen S; Schieffer H; Bette L
Z Kardiol; 1983 Dec; 72(12):746-54. PubMed ID: 6421002
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
Loskot F; Novotny P; Sucic P; Schneider G
Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
[TBL] [Abstract][Full Text] [Related]
8. [The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris].
Rettig GF; Jakob M; Koch HP
Z Kardiol; 1992 Oct; 81(10):525-30. PubMed ID: 1441691
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris.
Khurmi NS; O'Hara MJ; Bowles MJ; Subramanian VB; Raftery EB
Am J Cardiol; 1984 Mar; 53(6):684-8. PubMed ID: 6367415
[TBL] [Abstract][Full Text] [Related]
10. Objective evaluation of gallopamil in patients with chronic stable angina. Exercise testing, Holter monitoring, cross-sectional echocardiography and plasma levels.
Scrutinio D; Lagioia R; Mangini SG; Mastropasqua F; Ricci A; Chiddo A; Rizzon P
Eur Heart J; 1989 Feb; 10(2):168-76. PubMed ID: 2647495
[TBL] [Abstract][Full Text] [Related]
11. Gallopamil and diltiazem: a double-blind, randomized, cross-over trial in effort ischaemia.
Marraccini P; Orsini E; Brunelli C; Nassi G; Ghigliotti G; Iannetti M; Caponnetto S; L'Abbate A
Eur Heart J; 1992 Mar; 13(3):404-10. PubMed ID: 1597229
[TBL] [Abstract][Full Text] [Related]
12. Antianginal efficacy of gallopamil in comparison to nifedipine.
Rettig G; Sen S; Vogel W; Heisel A; Schieffer H; Bette L
Int J Cardiol; 1988 Jun; 19(3):315-25. PubMed ID: 3294189
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and duration of the effect of gallopamil sustained release in patients with chronic stable effort angina.
Lagioia R; Fila GT; Ramunni G; Mastropasqua F; Scrutinio D; Rizzon P
Cardiologia; 1991 Nov; 36(11):879-84. PubMed ID: 1817760
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
Kottkamp H; Gülker H; Emmerich K; Koch HP; Minge C
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S88-94. PubMed ID: 1284163
[TBL] [Abstract][Full Text] [Related]
15. Slow-release gallopamil in patients with stable effort angina.
Cherchi A; Lai C; Onnis E; Solinas R
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S75-82. PubMed ID: 1284161
[TBL] [Abstract][Full Text] [Related]
16. Slow-release gallopamil evaluated by exercise test and long-term electrocardiography.
Steinbeck G; Reuschel-Janetschek E
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S83-7. PubMed ID: 1284162
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dihydropyridine and phenylalkylamine calcium antagonists in patients with coronary heart disease.
Rettig GF; Jakob M; Sen S; Heisel A
Drugs; 1991; 42 Suppl 1():37-43. PubMed ID: 1718693
[TBL] [Abstract][Full Text] [Related]
18. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
Carboni GP; Saltarocchi ML; Risa AL; Scardovi AB; Zanchi E; Prati PL
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S64-70. PubMed ID: 1284159
[TBL] [Abstract][Full Text] [Related]
19. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Borer JS; Fox K; Jaillon P; Lerebours G;
Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of gallopamil versus nifedipine in patients with ischemic heart disease.
Molinero De Miguel E; Salcedo Arruti A; Sagastagoitia Gorostiza JD; Iriarte Ezkurdia MM; Fernandez Vidal P; Velasco Quintana J; Garrido García J
Int J Cardiol; 1993 Jul; 40(2):127-33. PubMed ID: 8349375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
